Local Multimodal Injection Versus Regional Anesthesia in Controlling Pain for Treating Rotational Ankle Fractures
Launched by UNIVERSITY OF UTAH · Aug 20, 2021
Trial Information
Current as of July 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Pain control is a chief domain in patient-centered care and may play a key role in outcome-driven reimbursement as a focus on payment strategies shifts in this direction. The Center for Medicaid and Medicare Services has developed the Total Performance Score for Hospitals, which is factored into the reimbursement for provided services. Pain Management is one of the main contributors to the score. Moreover, pain control has been shown to improve patient satisfaction, which is of increasing importance in medicine today.
The United States is in the midst of an opioid epidemic where we consume...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • isolated rotational ankle fracture
- • operative intervention needed
- • English or Spanish speaking
- • provide informed consent
- • able to communicate with the research team via email or phone
- Exclusion Criteria:
- • sustain concomitant head injury
- • additional lower extremity fracture(s)
- • open fracture
- • prior drug dependency
- • allergies to any of the ingredients in the local injection or peripheral nerve block
- • any history of stroke
- • major neurological deficit
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Salt Lake City, Utah, United States
Patients applied
Trial Officials
Justin Haller, MD
Principal Investigator
University of Utah Orthopaedics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials